Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001415889-24-000278

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 66,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Luptakova Katarina CHIEF MEDICAL OFFICER 2024-01-01 Grant or award · Restricted Stock Units +66,500 66,500 D: show line 1 in the form
Loading xslF345X05/form4-01032024_040105.xml…